-+ 0.00%
-+ 0.00%
-+ 0.00%

60 DEGREES PHARMACEUTICALS ENROLLS FIRST PATIENT IN TAFENOQUINE EXPANDED ACCESS CLINICAL STUDY FOR PERSISTENT (B. MICROTI) BABESIOSIS

Reuters·01/08/2025 13:02:12

Please log in to view news